Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;27(9):e70033.
doi: 10.1002/jgm.70033.

Liver Enzyme Genetics and Health Conditions in East Asians: Genetic Architecture and Causal Insights

Ying-Ju Lin  1   2 , Jai-Sing Yang  3 , Ju-Pi Li  4   5 , Jian-Shiun Chiou  6   7 , Ting-Yuan Liu  8 , Hsing-Fang Lu  8   9 , Chen-Hsing Chou  6   7 , Wen-Miin Liang  6 , I-Ching Chou  2   10   11 , Ting-Hsu Lin  1 , Chiu-Chu Liao  1 , Shao-Mei Huang  1 , Fuu-Jen Tsai  1   2   12   13
Affiliations

Liver Enzyme Genetics and Health Conditions in East Asians: Genetic Architecture and Causal Insights

Ying-Ju Lin et al. J Gene Med. 2025 Sep.

Abstract

Background: Elevated serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are biomarkers of liver dysfunction and predictors of cirrhosis and liver cancer. While European-ancestry GWAS have identified hundreds of loci influencing these enzymes and driven drug discovery and personalized interventions, comparable genetic studies in Han Taiwanese and other East Asian populations remain lacking.

Methods: We performed GWAS of ALT (n = 137,312) and AST (n = 111,527) in Han Taiwanese to characterize liver enzyme genetics. To assess broader East Asian relevance, we performed cross-trait genetic correlation analyses across five East Asian biobanks. We then conducted phenome-wide association studies (PheWAS) using polygenic risk scores (PRSs) to identify disease associations and applied bidirectional Mendelian randomization (MR) to assess causality.

Results: We identified 16 genome-wide significant loci-including novel East Asian variants-linking enzyme liability to metabolic, hematologic, and malignancy traits. PheWAS revealed strong links to endocrine-metabolic disorders, especially type 2 diabetes (T2D), and to circulatory, genitourinary, digestive, and infectious diseases. MR showed a causal effect of genetically elevated ALT on increased T2D risk; AST's effect was evident only after BMI adjustment. Neither enzyme showed a causal influence on malignancy, though genetic predisposition to malignancy was associated with lower ALT levels. PRSs for ALT and AST robustly predicted higher T2D risk and earlier onset.

Conclusion: These findings elucidated the genetic architecture of liver enzymes in Han Taiwanese and highlight their relevance across East Asian populations. ALT and AST PRSs show promise as genomic markers for diabetes risk and precision prevention.

Keywords: Mendelian randomization; health conditions; liver enzymes; polygenic risk score; single nucleotide polymorphism.

PubMed Disclaimer

References

    1. S. K. Asrani, H. Devarbhavi, J. Eaton, and P. S. Kamath, “Burden of Liver Diseases in the World,” Journal of Hepatology 70, no. 1 (2019): 151–171.
    1. Z. M. Younossi, G. Wong, Q. M. Anstee, and L. Henry, “The Global Burden of Liver Disease,” Clinical Gastroenterology and Hepatology 21, no. 8 (2023): 1978–1991.
    1. S. K. Sarin, M. Kumar, M. Eslam, et al., “Liver Diseases in the Asia‐Pacific Region: A Lancet Gastroenterology & Hepatology Commission,” Lancet Gastroenterology & Hepatology 5, no. 2 (2020): 167–228.
    1. A. S. Bhadoria, A. Mohapatra, R. Gupta, Y. K. Chawla, R. Kant, and S. Nundy, “Preventive Hepatology: An Ounce of Prevention or Pounds of Cure to Curb Liver Diseases,” Journal of Family Medicine and Primary Care 12, no. 3 (2023): 419–421.
    1. E. Trefts, M. Gannon, and D. H. Wasserman, “The Liver,” Current Biology 27, no. 21 (2017): R1147–R1151.

Substances

LinkOut - more resources